<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Draft Guidance for Industry on Controlled Correspondence Related to Generic Drug Development; Availability</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Draft Guidance for Industry on Controlled Correspondence Related to Generic Drug Development; Availability</h1>
    <p class="timestamp">Published: 2014-08-27 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA) is announcing the availability of a draft guidance for industry entitled "Controlled Correspondence Related to Generic Drug Development." The guidance document provides information regarding the process by which human generic drug manufacturers and related industry can submit correspondence to FDA requesting information on generic drug development. This guidance also describes FDA's process for providing communications related to such correspondence.</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2014-20359</p>
    <p><strong>Publication Date:</strong> 2014-08-27</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2014/08/27/2014-20359/draft-guidance-for-industry-on-controlled-correspondence-related-to-generic-drug-development">https://www.federalregister.gov/documents/2014/08/27/2014-20359/draft-guidance-for-industry-on-controlled-correspondence-related-to-generic-drug-development</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2014-20359</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
